Under Armour Inc Class A vs 22nd Century Group Inc — how do they compare? Under Armour Inc Class A trades at $4.93 (market cap $2.07B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Under Armour Inc Class A is far larger — about 3329.7× 22nd Century Group Inc's market cap, and Under Armour Inc Class A is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Under Armour Inc Class A for 99 Days and 22nd Century Group Inc for 32 Days on average.
| UAA | XXII | |
|---|---|---|
Market Cap | $2.07B | $621.67K |
Volume | 12,050,442 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $8.14 | $483.00 |
52-Week Low | $4.17 | $0.80 |
Typical Hold Time | 99 Days | 32 Days |
Enterprise Value | $3.05B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Under Armour (UAA) trades at $4.88, up 1.24% with a mixed technical picture showing bullish moving averages but neutral oscillators. The company faces fundamental challenges with negative net income margins (-9.99%) and declining revenue trends, though valuation metrics like P/S (0.42) appear attractive. Recent news highlights brand transformation efforts amid softer demand, with the company maintaining profitability outlook despite revenue cuts.
The outlook remains cautious with significant execution risks as Under Armour navigates weak consumer spending. Analyst consensus shows modest upside to the $5.79 price target, but persistent revenue declines and negative cash flow trends pose substantial headwinds for shareholder value recovery in the near term.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →